Literature DB >> 1615490

Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator.

A de Boer1, C Kluft, J M Kroon, F J Kasper, H C Schoemaker, J Pruis, D D Breimer, P A Soons, J J Emeis, A F Cohen.   

Abstract

The influence of changes in liver blood flow on the clearance of rt-PA was studied both in healthy subjects and in a perfused rat liver model. Liver blood flow in healthy subjects was documented indirectly by the clearance of indocyanine green (ICG). Exercise reduced liver blood flow on average by 57% with a 95% confidence interval (95% CI) ranging from 51% to 62% (n = 5) and increased plasma levels of rt-PA activity (after an i.v. infusion of 18 mg of rt-PA over 120 min) by 119% (95% CI, 58%-203%) and rt-PA antigen by 91% (95% CI, 30%-140%). In the perfused rat liver model it was shown that halving or doubling of the physiological flow rate of a perfusate, containing rt-PA caused a proportional change in the clearance of rt-PA, while the extraction of rt-PA by the liver remained similar. In conclusion, liver blood flow is a major determinant of the clearance of rt-PA. This may have important implications for dosage of rt-PA in patients with myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1615490

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  12 in total

1.  Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years.

Authors:  D Kim; G A Ford; C S Kidwell; S Starkman; F Vinuela; G R Duckwiler; R Jahan; J L Saver
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

2.  Interventional stroke therapies in the elderly: are we helping?

Authors:  N Zeevi; G A Kuchel; N S Lee; I Staff; L D McCullough
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-24       Impact factor: 3.825

Review 3.  Management of acute ischaemic stroke in the elderly: tolerability of thrombolytics.

Authors:  D Tanne; D Turgeman; Y Adler
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease.

Authors:  D de Bono
Journal:  Br Heart J       Date:  1994-06

5.  Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening.

Authors:  Costas G Hadjipanayis; Huabei Jiang; David W Roberts; Lily Yang
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

Review 6.  Molecular Targeted Fluorescence-Guided Intraoperative Imaging of Bladder Cancer Nodal Drainage Using Indocyanine Green During Radical and Partial Cystectomy.

Authors:  Manish N Patel; Ashok K Hemal
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

Review 7.  Drug interactions with thrombolytic agents. Current perspectives.

Authors:  A de Boer; J M van Griensven
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

8.  Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.

Authors:  A De Boer; C Kluft; F J Kasper; J M Kroon; H C Schoemaker; D D Breimer; P A Soons; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

Review 9.  Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients.

Authors:  Hakan Sarikaya
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

10.  The influence of nifedipine and captopril on liver blood flow in healthy subjects.

Authors:  J Burggraaf; R C Schoemaker; J M Kroon; A F Cohen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.